Health Condition 1: M95-M95- Other disorders of the musculoskeletal system and connective tissue
Conditions
Interventions
Intervention1: Group ESP(E): Group (E)- 30ml of 0.25% Bupivacaine + Triamcinolone 20mg USG guided
(3 month)
Control Intervention1: Group TFS(T): Group TFS(T)- 2.0ml of 0.25% Bupivacaine + Triamcinolon
Sponsors
IMS BHU
Eligibility
Inclusion criteria
Inclusion criteria: 1.ASA grade 1 and 2 2.Patient with low back ache with unilateral radicular pain persisting despite medical treatment
Exclusion criteria
Exclusion criteria: Patient refusal Coagulation disorders Allergic to Local Anesthetic agents Presence of infection at injection area Patient with previous history of spinal surgery Patient with co morbidities Spinal cord disease like scoliosis or mechanical instability like fracture More than 2 level of disc hernia Degenerated and sequestered disc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain levels by Numeric rating scale (NRS)Timepoint: Immediately(With in 30 mins) | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain level after intervention at 1 month , 3 month by Numeric rating scale. Oswestry disability index Patient requiring rescue Analgesia ComplicationsTimepoint: 1 month and 3 month | — |
Countries
India
Contacts
Public ContactProf Anil Kumar Paswan
Banaras Hindu University
Outcome results
None listed